Evidence map›Paper›PMID 21706192›Full record

ArticleIrish journal of medical science2011

Warfarin anticoagulation: a survey of patients' knowledge of their treatment.

S M Moran, N Fitzgerald, M Pope, M Madden, C J Vaughan

Abstract read
PubMed Publisher
In one paragraph

Article in Irish journal of medical science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

S M MoranDepartment of Cardiology, Mercy University Hospital, Grenville Place, Cork, Ireland. moransarah@gmail.com
N Fitzgerald
M Pope
M Madden
C J Vaughan
Mercy University Hospital · IEUniversity College Cork · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWarfarin is used for the treatment of thromboembolic disease. It requires careful and sustained monitoring due to its narrow therapeutic index and potentially life-threatening complications. Patient education and knowledge is, therefore, vital.

aimsTo assess, in a specialised anticoagulation clinic, the extent of patients' knowledge of their warfarin treatment.

methodsEthical approval was obtained. All patients, aged over 18 years, attending our anticoagulation clinic during our study period were asked to participate.

resultsWe enrolled 181 patients, 47.9% of respondents were unaware of any potential drug interactions, 57.7% of patients were unaware of any potential side effects, 20% of patients had experienced side effects, 10.9% of patients had been hospitalised due to side effects, 58% of which were due to Haemorrhage and 79% of patients kept a personal record of their INR.

conclusionsPatients' understanding of warfarin treatment was poor, despite their high level of compliance.

Indexed as

Health Knowledge, Attitudes, PracticeAgedAged, 80 and overAnticoagulantsFemaleHumansMaleMedication AdherenceMiddle AgedPatient Education as TopicSurveys and QuestionnairesWarfarinAnticoagulantsWarfarin

Identifiers

PMID21706192
OpenAlexW1989742955

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.